Literature DB >> 21628350

Thirty years of HIV and AIDS: future challenges and opportunities.

Carl W Dieffenbach1, Anthony S Fauci.   

Abstract

As the third decade since AIDS was first recognized comes to an end, extraordinary advances have occurred in the understanding, treatment, and prevention of HIV infection and AIDS. As a result of these successes, it is now time to focus on future challenges. Paramount among these is reaching the goal of truly controlling and ultimately ending the HIV and AIDS pandemic. To that end, AIDS researchers and public health personnel worldwide are aggressively pursuing 3 key areas of scientific research. Given the availability of highly effective therapeutic regimens for HIV infection, the first challenge is efficiently identifying a maximum number of HIV-infected persons through voluntary HIV testing and initiating antiretroviral therapy (ART). Second, scientists are trying to develop a cure for HIV infection, which would alleviate the need for lifelong ART. Finally, preventing new cases of HIV infection, which currently number approximately 2.6 million per year globally, is critical to any attempt to end this pandemic. This article addresses each of these challenges and provides directions for the future.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628350     DOI: 10.7326/0003-4819-154-11-201106070-00345

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  59 in total

1.  Breaking Down the Siloes: Developing Effective Multidisciplinary HIV Research Teams.

Authors:  Manya Magnus; Amanda Castel
Journal:  AIDS Behav       Date:  2016-09

2.  An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men.

Authors:  Abigail J S Armstrong; Michael Shaffer; Nichole M Nusbacher; Christine Griesmer; Suzanne Fiorillo; Jennifer M Schneider; C Preston Neff; Sam X Li; Andrew P Fontenot; Thomas Campbell; Brent E Palmer; Catherine A Lozupone
Journal:  Microbiome       Date:  2018-11-05       Impact factor: 14.650

Review 3.  Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications.

Authors:  Douglas Krakower; Kenneth H Mayer
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

4.  Getting Personal: Progress and Pitfalls in HIV Prevention Among Latinas.

Authors:  Hortensia Amaro; Anita Raj; Elizabeth Reed; Monica Ulibarri
Journal:  Psychol Women Q       Date:  2011-12-01

5.  Evaluating the Impact of a HIV Low-Risk Express Care Task-Shifting Program: A Case Study of the Targeted Learning Roadmap.

Authors:  Linh Tran; Constantin T Yiannoutsos; Beverly S Musick; Kara K Wools-Kaloustian; Abraham Siika; Sylvester Kimaiyo; Mark J van der Laan; Maya Petersen
Journal:  Epidemiol Methods       Date:  2016-11-10

Review 6.  Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.

Authors:  Sai Shashank Chavali; Rachel Bonn-Breach; Joseph E Wedekind
Journal:  J Biol Chem       Date:  2019-05-12       Impact factor: 5.157

7.  Controversies in HIV cure research.

Authors:  Rowena Johnston; Françoise Barré-Sinoussi
Journal:  J Int AIDS Soc       Date:  2012-03-16       Impact factor: 5.396

Review 8.  Developing strategies for HIV-1 eradication.

Authors:  Christine M Durand; Joel N Blankson; Robert F Siliciano
Journal:  Trends Immunol       Date:  2012-08-03       Impact factor: 16.687

9.  Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex.

Authors:  Arun K Ghosh; Margherita Brindisi; Prasanth R Nyalapatla; Jun Takayama; Jean-Rene Ella-Menye; Sofiya Yashchuk; Johnson Agniswamy; Yuan-Fang Wang; Manabu Aoki; Masayuki Amano; Irene T Weber; Hiroaki Mitsuya
Journal:  Bioorg Med Chem       Date:  2017-04-09       Impact factor: 3.641

10.  Design, Synthesis, Biological Evaluation, and X-ray Studies of HIV-1 Protease Inhibitors with Modified P2' Ligands of Darunavir.

Authors:  Arun K Ghosh; W Sean Fyvie; Margherita Brindisi; Melinda Steffey; Johnson Agniswamy; Yuan-Fang Wang; Manabu Aoki; Masayuki Amano; Irene T Weber; Hiroaki Mitsuya
Journal:  ChemMedChem       Date:  2017-11-24       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.